Artiva Other Operating Expenses from 2010 to 2024

ARTV Stock   11.04  0.64  6.15%   
Artiva Biotherapeutics, Other Operating Expenses yearly trend continues to be fairly stable with very little volatility. Other Operating Expenses will likely drop to about 55.7 M in 2024. Other Operating Expenses is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. View All Fundamentals
 
Other Operating Expenses  
First Reported
2010-12-31
Previous Quarter
64.2 M
Current Value
55.7 M
Quarterly Volatility
19.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Artiva Biotherapeutics, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Artiva Biotherapeutics,'s main balance sheet or income statement drivers, such as Net Interest Income of 2.7 M, Interest Income of 2.7 M or Depreciation And Amortization of 2.4 M, as well as many indicators such as Price To Sales Ratio of 3.18, Dividend Yield of 0.0 or Days Sales Outstanding of 18.2. Artiva financial statements analysis is a perfect complement when working with Artiva Biotherapeutics, Valuation or Volatility modules.
  
Check out the analysis of Artiva Biotherapeutics, Correlation against competitors.

Latest Artiva Biotherapeutics,'s Other Operating Expenses Growth Pattern

Below is the plot of the Other Operating Expenses of Artiva Biotherapeutics, Common over the last few years. Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Artiva Biotherapeutics,. It is also known as Artiva Biotherapeutics, overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. It is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. Artiva Biotherapeutics,'s Other Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Artiva Biotherapeutics,'s overall financial position and show how it may be relating to other accounts over time.
Other Operating Expenses10 Years Trend
Slightly volatile
   Other Operating Expenses   
       Timeline  

Artiva Other Operating Expenses Regression Statistics

Arithmetic Mean29,390,447
Geometric Mean25,065,659
Coefficient Of Variation65.46
Mean Deviation16,308,522
Median18,271,000
Standard Deviation19,237,667
Sample Variance370.1T
Range46.5M
R-Value0.76
Mean Square Error167.2T
R-Squared0.58
Significance0.001
Slope3,277,368
Total Sum of Squares5181.2T

Artiva Other Operating Expenses History

202455.7 M
202364.2 M
202264.8 M
202155.3 M

About Artiva Biotherapeutics, Financial Statements

Artiva Biotherapeutics, investors use historical fundamental indicators, such as Artiva Biotherapeutics,'s Other Operating Expenses, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Artiva Biotherapeutics,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Operating Expenses64.2 M55.7 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Artiva Stock Analysis

When running Artiva Biotherapeutics,'s price analysis, check to measure Artiva Biotherapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artiva Biotherapeutics, is operating at the current time. Most of Artiva Biotherapeutics,'s value examination focuses on studying past and present price action to predict the probability of Artiva Biotherapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artiva Biotherapeutics,'s price. Additionally, you may evaluate how the addition of Artiva Biotherapeutics, to your portfolios can decrease your overall portfolio volatility.